Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-04-25FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) by Verity Pharmaceuticals Inc.
-
FDA approval · 2013-04-25FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approves Verity Pharmaceuticals' supplemental application for TRELSTAR (triptorelin pamoate).
-
CLINICAL_TRIALS research · 2013-04-25Clinical Trial Update: Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer [Phase 3]
Phase 3 clinical trial comparing conformal radiotherapy alone versus conformal radiotherapy combined with HDR brachytherapy or stereotactic …
-
CLINICAL_TRIALS withdrawal · 2013-04-24Clinical Trial Update: Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate [Phase 1]
A Phase 1 trial evaluating radiation therapy followed by surgery for high-risk localized prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-04-19Clinical Trial Update: An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001 [Phase 1]
An expanded access study of Abiraterone Acetate for advanced prostate cancer has completed after COU-AA-001.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Docetaxel and Prednisone With or Without Bevacizumab in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 3]
A Phase 3 trial evaluated adding bevacizumab to docetaxel and prednisone in men with hormone-refractory prostate cancer; results were posted…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer [Phase 1]
A Phase 1 pharmacokinetics study comparing abiraterone acetate capsule and tablet formulations in patients with prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer [Phase 2]
The document reports the completion of a Phase 2 trial evaluating the safety and efficacy of abiraterone acetate in men with prostate cancer…
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Early Stage Prostate Cancer Cohort
This clinical trial update notes that the early-stage prostate cancer cohort has completed. The trial is listed as status COMPLETED.
-
CLINICAL_TRIALS research · 2013-04-12Clinical Trial Update: Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer
Clinical trial update on growth factor levels in the blood of patients undergoing radiation therapy for epithelial cancers. The study status…
-
FDA approval · 2013-04-11FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., resulting in a label update und…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) [Phase 2]
A Phase 2 study evaluating CP-751,871 in combination with docetaxel and prednisone in hormone-insensitive prostate cancer has completed and …
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating quinacrine in androgen-independent prostate cancer has completed, with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer [Phase 3]
This clinical trial update reports on a Phase 3 comparison of long-acting versus short-acting LHRH agonists in the treatment of prostate can…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel plus a phytochemical for hormone-independent metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors [Phase 1]
Phase 1 study of Alvespimycin hydrochloride in patients with metastatic or unresectable solid tumors has been completed, evaluating safety a…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Satraplatin and Prednisone to Treat Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating satraplatin plus prednisone for prostate cancer has completed; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies [NA]
This clinical trial compared transrectal ultrasonography-guided saturation biopsy with a 10-12 core biopsy in men undergoing repeat prostate…
-
CLINICAL_TRIALS withdrawal · 2013-04-08Clinical Trial Update: Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer [Phase 3]
A Phase 3 clinical trial evaluating radiation therapy for Stage I-III prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Phase 2]
A completed Phase 2 trial evaluating dolastatin-10 in patients with metastatic prostate cancer that did not respond to prior hormone therapy…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluated adding isoflavones to radiation therapy for localized prostate cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer [Phase 2, Phase 3]
This completed Phase 2/3 randomized trial compared seminal vesicle-sparing prostatectomy with nerve-sparing radical prostatectomy in men wit…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer [Phase 2]
Phase II study evaluating PROSTVAC-V and PROSTVAC-F vaccines with GM-CSF in prostate cancer patients with PSA progression after local therap…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Biological Therapy in Treating Patients With Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating a biological therapy for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: Vinflunine in Hormone Refractory Prostate Cancer (HRPC) [Phase 2]
Phase 2 clinical trial update for vinflunine in hormone-refractory prostate cancer has completed with results posted in 2013.